Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1977 Apr;4(2):97–100. doi: 10.1111/j.1365-2125.1977.tb00678.x

Oral absorption and secretion of drugs.

C F Speirs
PMCID: PMC1429012  PMID: 324505

Full text

PDF
97

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BENDER I. B., PRESSMAN R. S., TASHMAN S. G. Studies on excretion of antibiotics in human saliva. I. Penicillin and streptomycin. J Am Dent Assoc. 1953 Feb;46(2):164–170. doi: 10.14219/jada.archive.1953.0018. [DOI] [PubMed] [Google Scholar]
  2. Beckett AH BOYES R. N., Triggs E. J. Kinetics of buccal absorption of amphetamines. J Pharm Pharmacol. 1968 Feb;20(2):92–97. doi: 10.1111/j.2042-7158.1968.tb09695.x. [DOI] [PubMed] [Google Scholar]
  3. Beckett A. H., Moffat A. C. Kinetics of buccal absorption of some carboxylic acids and the correlation of the rate constants and n-heptane: aqueous phase partition coefficients. J Pharm Pharmacol. 1970 Jan;22(1):15–19. doi: 10.1111/j.2042-7158.1970.tb08378.x. [DOI] [PubMed] [Google Scholar]
  4. Beckett A. H., Moffat A. C. The buccal absorption of some barbiturates. J Pharm Pharmacol. 1971 Jan;23(1):15–18. doi: 10.1111/j.2042-7158.1971.tb12774.x. [DOI] [PubMed] [Google Scholar]
  5. Brooks P. M., Bell M. A., Burns H. Salivary antipyrine half-life: a useful measure of hepatic drug metabolism. Br J Clin Pharmacol. 1976 Oct;3(5):945–946. doi: 10.1111/j.1365-2125.1976.tb00656.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chang R. L., Wood A. W., Dixon W. R., Conney A. H., Anderson K. E., Eiseman J., Alvares A. P. Antipyrine: radioimmunoassay in plasma and saliva following administration of a high dose and a low dose. Clin Pharmacol Ther. 1976 Aug;20(2):219–226. doi: 10.1002/cpt1976202219. [DOI] [PubMed] [Google Scholar]
  7. Fraser H. S., Bulpitt C. J., Kahn C., Mould G., Mucklow J. C., Dollery C. T. Factors affecting antipyrine metabolism in West African villagers. Clin Pharmacol Ther. 1976 Sep;20(3):369–376. doi: 10.1002/cpt1976203369. [DOI] [PubMed] [Google Scholar]
  8. GIBALDI M., KANIG J. L. ABSORPTION OF DRUGS THROUGH THE ORAL MUCOSA. J Oral Ther Pharmacol. 1965 Jan;1:440–450. [PubMed] [Google Scholar]
  9. Galeazzi R. L., Benet L. Z., Sheiner L. B. Relationship between the pharmacokinetics and pharmacodynamics of procainamide. Clin Pharmacol Ther. 1976 Sep;20(3):278–289. doi: 10.1002/cpt1976203278. [DOI] [PubMed] [Google Scholar]
  10. George C. F. Diseases of the alimentary system. Absorption, distribution, and metabolism of drugs; effects of disease of the gut. Br Med J. 1976 Sep 25;2(6038):742–744. doi: 10.1136/bmj.2.6038.742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Glynn J. P., Bastain W. Salivary excretion of paracetamol in man. J Pharm Pharmacol. 1973 May;25(5):420–421. doi: 10.1111/j.2042-7158.1973.tb10042.x. [DOI] [PubMed] [Google Scholar]
  12. Graham G., Rowland M. Application of salivary salicylate data to biopharmaceutical studies of salicylates. J Pharm Sci. 1972 Aug;61(8):1219–1222. doi: 10.1002/jps.2600610810. [DOI] [PubMed] [Google Scholar]
  13. Hoeprich P. D. Prediction of antimeningococcic chemoprophylactic efficacy. J Infect Dis. 1971 Feb;123(2):125–133. doi: 10.1093/infdis/123.2.125. [DOI] [PubMed] [Google Scholar]
  14. Huffman D. H. Relationship between digoxin concentrations in serum and saliva. Clin Pharmacol Ther. 1975 Mar;17(3):310–312. doi: 10.1002/cpt1975173310. [DOI] [PubMed] [Google Scholar]
  15. Inaba T., Kalow W. Salivary excretion of amobarbital in man. Clin Pharmacol Ther. 1975 Nov;18(5 Pt 1):558–562. doi: 10.1002/cpt1975185part1558. [DOI] [PubMed] [Google Scholar]
  16. Joselow M. M., Ruiz R., Goldwater L. J. The use of salivary (parotid) fluid in biochemical monitoring. Am Ind Hyg Assoc J. 1969 Jan-Feb;30(1):77–82. doi: 10.1080/00028896909343083. [DOI] [PubMed] [Google Scholar]
  17. Koysooko R., Ellis E. F., Levy G. Relationship between theophylline concentration in plasma and saliva of man. Clin Pharmacol Ther. 1974 May;15(5):454–460. doi: 10.1002/cpt1974155454. [DOI] [PubMed] [Google Scholar]
  18. Letter: Exercise and the heart. Lancet. 1976 Mar 20;1(7960):639–640. [PubMed] [Google Scholar]
  19. Matin S. B., Wan S. H., Karam J. H. Pharmacokinetics of tolbutamide: prediction by concentration in saliva. Clin Pharmacol Ther. 1974 Dec;16(6):1052–1058. doi: 10.1002/cpt19741661052. [DOI] [PubMed] [Google Scholar]
  20. Paxton J. W., Whiting B., Stephen K. W. Phenytoin concentrations in mixed, parotid and submandibular saliva and serum measured by radioimmunoassay. Br J Clin Pharmacol. 1977 Apr;4(2):185–191. doi: 10.1111/j.1365-2125.1977.tb00692.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Reynolds F., Ziroyanis P. N., Jones N. F., Smith S. E. Salivary phenytoin concentrations in epilepsy and in chronic renal failure. Lancet. 1976 Aug 21;2(7982):384–386. doi: 10.1016/s0140-6736(76)92404-1. [DOI] [PubMed] [Google Scholar]
  22. Salivary concentrations of antiepileptic drugs. Lancet. 1976 Sep 18;2(7986):639–640. [PubMed] [Google Scholar]
  23. Schmidt D., Kupferberg J. Diphenylhydantoin, phenobarbital, and primidone in saliva, plasma, and cerebrospinal fluid. Epilepsia. 1975 Dec;16(5):735–741. doi: 10.1111/j.1528-1157.1975.tb04758.x. [DOI] [PubMed] [Google Scholar]
  24. Speirs C. F., Stenhouse D., Stephen K. W., Wallace E. T. Comparison of human serum, parotid and mixed saliva levels of phenoxymethylpenicillin, ampicillin, cloxacillin and cephalexin. Br J Pharmacol. 1971 Sep;43(1):242–247. doi: 10.1111/j.1476-5381.1971.tb07173.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Stephen K. W., Speirs C. F. Methods for collecting individual components of mixed saliva: the relevance to clinical pharmacology. Br J Clin Pharmacol. 1976 Apr;3(2):315–319. doi: 10.1111/j.1365-2125.1976.tb00609.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES